Skip to content
mapperlab
← Dashboard
Stock

SHC

Sotera Health Co
Health CareHealth Care ServicesLatest close $158 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
8
27 funds tracked
Ever held
10
Current + past
New this quarter
1
Exited this quarter
1

Marquee-fund ownership over time

Aug 14, 2023Nov 14, 2024Nov 14, 2025May 15, 2026
Now
8

This quarter's activity

New positions opened

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Greenlight Capital$17$15-9%
Citadel Advisors re-entered$15$15+4%
AQR Capital Management$15$15+4%
Millennium Management re-entered$15$15+4%
Point72 Asset Management re-entered$15$15+4%
Renaissance Technologies$17$15-10%
Two Sigma Investments$17$15-10%
Bridgewater Associates$15$15+1%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
D.E. Shaw→ $15+2%
Maverick Capital→ $13+18%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Sotera Health Co. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
14
Filings · last 90d
22
Total on file
138
Recent SEC buffer
Most recent
May 27, 2026

30d / 90d windows measured from May 27, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 138 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · Sotera Health Co

Annual figures sourced directly from Sotera Health Co's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$1.16B
FY2025+6% YoY
Net income
$77.95M
FY2025+76% YoY
EPS (diluted)
$0.2700
FY2025+69% YoY
Free cash flow(?)
$149.18M
FY2025+231% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Sotera Health Co — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Bridgewater AssociatesQ2 2026open$15$15-3%
Two Sigma InvestmentsQ1 2026open$17$15-10%
Point72 Asset ManagementQ1 2026open$17$15-10%
Renaissance TechnologiesQ1 2026open$17$15-10%
Point72 Asset ManagementQ3 2025Q4 2025$16$16-1%
Citadel AdvisorsQ2 2025open$13$15+20%
Millennium ManagementQ2 2025open$13$15+20%
D.E. ShawQ4 2024Q2 2026$15$15+2%
Citadel AdvisorsQ3 2024Q1 2025$15$13-8%
AQR Capital ManagementQ3 2024open$15$15+4%
Millennium ManagementQ3 2024Q1 2025$15$13-8%
Point72 Asset ManagementQ3 2024Q4 2024$15$15+2%
Maverick CapitalQ2 2024Q1 2025$11$13+18%
Greenlight CapitalQ3 2023open$17$15-9%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.